GlassScriptPhysician profile
Riteesha G Reddy
NPI 1912127572
$4,548.35
in general payments reported to CMS, 2019-2025
40 companies · $1,536 in 2025
The $1,536 reported for 2025 was more than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $803 · 2020: $162 · 2021: $29.80 · 2022: $247 · 2023: $756 · 2024: $1,015 · 2025: $1,536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,306.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $666.33 | 2019-2025 | Evenity, Prolia, Otezla |
| Novartis Pharmaceuticals Corporation | $620.66 | 2019-2025 | |
| Abbvie INC. | $372.33 | 2019-2025 | |
| Aop Health US, LLC | $372.11 | 2025 | Rapiblyk |
| Pfizer INC. | $355.16 | 2019-2025 | |
| Novo Nordisk INC | $287.07 | 2023-2025 | Wegovy, Saxenda |
| Abbott Laboratories | $239.32 | 2024-2025 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $233.83 | 2019-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $218.75 | 2022-2025 | Xifaxan |
| Itamar Medical INC | $115.06 | 2022 | |
| Mylan Specialty L.P. | $99.21 | 2023-2024 | Yupelri |
| Ucb, INC. | $87.17 | 2019-2024 | Bimzelx, Cimzia |
| Esperion Therapeutics, INC. | $85.54 | 2024-2025 | Nexletol |
| Sobi, INC | $65.26 | 2019 | |
| Cleerly, INC. | $61.55 | 2025 | Cleerly Ischemia, Cleerly Labs |
Show all 39 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Riteesha Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.